Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults

Journal of the American Geriatrics Society

Volumn 60, Issue 3, 2012, Pages 499-504

  Zheng, Ling ^a   MacK, Wendy J ^a   Chui, Helena C ^a   Heflin, Lara ^b   Mungas, Dan ^c   Reed, Bruce ^c   Decarli, Charles ^c   Weiner, Michael W ^d,e   Kramer, Joel H ^e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cognitive decline; cognitively normal elderly adults; coronary artery disease; magnetic resonance imaging

Indexed keywords

AGED; ARTICLE; COGNITIVE DEFECT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; VERBAL MEMORY;

AGED; AGED, 80 AND OVER; CALIFORNIA; COGNITION DISORDERS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84858337209     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03839.x     Document Type: Article

References (30)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 2010; 121: 948-954.
2. McNeill AM, Katz R, Girman CJ, et al. Metabolic syndrome and cardiovascular disease in older people: The Cardiovascular Health Study. J Am Geriatr Soc 2006; 54: 1317-1324.
3. Blair CK, Folsom AR, Knopman DS, et al. APOE genotype and cognitive decline in a middle-aged cohort. Neurology 2005; 64: 268-276.
4. Breteler MM,. Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann N Y Acad Sci 2000; 903: 457-465.
5. Cechetto DF, Hachinski V, Whitehead SN,. Vascular risk factors and Alzheimer's disease. Expert Rev Neurother 2008; 8: 743-750.
6. Cerhan JR, Folsom AR, Mortimer JA, et al. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology 1998; 44: 95-105.
7. Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42-48.
8. Pavlik VN, Hyman DJ, Doody R,. Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III). Neuroepidemiology 2005; 24: 42-50.
9. Llewellyn DJ, Lang IA, Xie J, et al. Framingham Stroke Risk Profile and poor cognitive function: A population-based study. BMC Neurol 2008; 8: 12.
10. Selnes OA, Goldsborough MA, Borowicz LM Jr, et al. Determinants of cognitive change after coronary artery bypass surgery: A multifactorial problem. Ann Thorac Surg 1999; 67: 1669-1676.
11. Borowicz LM, Goldsborough MA, Selnes OA, et al. Neuropsychologic change after cardiac surgery: A critical review. J Cardiothorac Vasc Anesth 1996; 10: 105-111, quiz 111-112.
12. Debette S, Beiser A, DeCarli C, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: The Framingham Offspring Study. Stroke 2010; 41: 600-606.
13. Seshadri S, Wolf PA, Beiser A, et al. Stroke risk profile, brain volume, and cognitive function: The Framingham Offspring Study. Neurology 2004; 63: 1591-1599.
14. van Dijk EJ, Prins ND, Vrooman HA, et al. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan Study. Stroke 2008; 39: 2712-2719.
15. Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: The Cardiovascular Health Study. Stroke 2005; 36: 56-61.
16. Kramer JH, Mungas D, Reed BR, et al. Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology 2007; 21: 412-418.
17. Saxton J, Ratcliff G, Newman A, et al. Cognitive test performance and presence of subclinical cardiovascular disease in the Cardiovascular Health Study. Neuroepidemiology 2000; 19: 312-319.
18. Carey CL, Kramer JH, Josephson SA, et al. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke 2008; 39: 397-402.
19. Fein G, Di Sclafani V, Tanabe J, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000; 55: 1626-1635.
20. Chui HC, Zarow C, Mack WJ, et al. Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol 2006; 60: 677-687.
21. Jagust WJ, Zheng L, Harvey DJ, et al. Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol 2008; 63: 72-80.
22. Mungas D, Reed BR, Kramer JH,. Psychometrically matched measures of global cognition, memory, and executive function for assessment of cognitive decline in older persons. Neuropsychology 2003; 17: 380-392.
23. Reed BR, Mungas DM, Kramer JH, et al. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain 2007; 130: 731-739.
24. Watson C, Andermann F, Gloor P, et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992; 42: 1743-1750.
25. Jouvent E, Viswanathan A, Mangin JF, et al. Brain atrophy is related to lacunar lesions and tissue microstructural changes in CADASIL. Stroke 2007; 38: 1786-1790.
26. O'Sullivan M, Singhal S, Charlton R, et al. Diffusion tensor imaging of thalamus correlates with cognition in CADASIL without dementia. Neurology 2004; 62: 702-707.
27. Selnes OA, Grega MA, Bailey MM, et al. Do management strategies for coronary artery disease influence 6-year cognitive outcomes? Ann Thorac Surg 2009; 88: 445-454.
28. Gunning-Dixon FM, Raz N,. The cognitive correlates of white matter abnormalities in normal aging: A quantitative review. Neuropsychology 2000; 14: 224-232.
29. Schmidt R, Ropele S, Enzinger C, et al. White matter lesion progression, brain atrophy, and cognitive decline: The Austrian Stroke Prevention Study. Ann Neurol 2005; 58: 610-616.
30. van den Heuvel DM, ten Dam VH, de Craen AJ, et al. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. J Neurol Neurosurg Psychiatry 2006; 77: 149-153.